
Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com
BEFORE THE BELL: EUROPE RECOVERS, EYES ON INFLATION, EARNINGS
European shares were set to bounce back on Wednesday as Ukraine accepted a US-proposed ceasefire, and President Donald Trump sought to ease concerns over a recession at a business roundtable following this week's rout on Wall Street.
Inflation data in the United States was awaited, and any higher-than-expected reading might fuel concerns of stagflation in the world's largest economy. Eyes were also on Russia's response to the American ceasefire plan.
EuroSTOXX50, DAX, and FTSE futures were last up 0.2-0.8%, after tariff concerns set the broader European stock market to over 1-month lows the day before.
U.S. contracts steadied after losses on Tuesday that added to the biggest selloff in months due to growing concerns about the impact of the latest tariff threats on the global economy.
It was a heavy earnings day too.
Among the highlights, Rheinmetall RHMG.DE expects significant sales growth in 2025 and promised to update guidance after recent geopolitical developments are taken into account.
Zara owner Inditex ITX.MC on Wednesday reported quarterly sales in line with expectations, sealing another year of strong growth for the world's biggest listed fast-fashion retailer.
Luxury carmaker Porsche p911_p.DE will keep its dividend for 2024 at the previous year's level despite a 30% profit drop.
Over in the UK, Legal & General LGEN.L beat profit expectations and outlined plans to return more than 5 billion pounds to investors over the next three years.
Elswhwere, Zealand Pharma ZELA.CO was set for a big bounce after Roche ROG.S acquired rights to an obesity therapy by the Danish biotech firm in a deal worth up to $5.3 billion.
A disappointing outlook could hit Puma PUMG.DE shares.
(Danilo Masoni)
EARLIER ON LIVE MARKETS:
UKRAINE TALKS LIFT EURO BUT TARIFF WORRIES LINGER CLICK HERE